Having trouble viewing this email? View in your browser.
ESCMID Logo

28 January 2020
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

 

ECCMID 2020 is approaching: don’t miss the opportunity to enjoy Prof. Laura Piddock’s Keynote Lecture.
Register now!

We are extremely pleased to have Prof. Piddock (Professor of Microbiology at the University of Birmingham, United Kingdom) as a keynote speaker at ECCMID 2020! The title of her lecture will be “MDR efflux: from basic science to efflux inhibitors”.

Visit the ECCMID 2020 website to find out about our outstanding keynote speakers and register now!

› Read more

Open call to join the CMI editorial team

Clinical Microbiology and Infection (CMI) is looking for an editor in clinical microbiology to join the editorial team. They are looking for an editor who will deal mainly with studies done in the laboratory, whether the routine clinical laboratory or a research one. CMI aims to aid the readers in using research evidence for the benefit of patients. Improving the methods and the reporting of results is a worthy goal, and you can contribute by being an editor. The call is open until March 31st 2020. Read more about the call and how to apply for this opportunity here.

› Read more

2019-nCoV Updates – PREPARE and EITaF

With the emerging outbreak of a novel coronavirus in Hubei province, China, updates have been published by several of ESCMID’s affiliates.

The Platform for European Preparedness Against (Re-) emerging Epidemics (PREPARE), of which ESCMID is a partner, released a statement on Tuesday addressing the coronavirus outbreak and how they are preparing a response, checking the readiness of their network of 1000 hospitals and 900 labs across Europe.

The ESCMID Emerging Infections Task Force (EITaF) has published several pieces on the outbreak, including a comprehensive case definition summary, incorporating the definitions by the CDC, ECDC and WHO. Find out more on the EITaF Outbreak News page.

› Read more
 

EITaF Mailing list: Subscribe to receive outbreak news in your inbox!

Did you know that you can now receive email alerts every time that a new piece of EITaF Outbreak News is published?

If you log in to your ESCMID account using your ESCMID login credentials and choose the link ‘Newsletter and Mailing List’ in the right-hand column, You can opt-in to receiving EITaF news alerts.

› Read more
 

Applications are now being accepted for ESCMID funded Observerships at the Mayo Clinic in Rochester (USA)

Did you know that applications are now beeing accepted until 7. February, 12:00 (CET) for one ESCMID funded observership at the Mayo Clinic in Rochester (USA). Please note: This ESCMID funded observership is only available for Young Scientist Members, if they fulfill the eligibility criteria described on the ESCMID website. Use the link below to get directed to the website and submit your application to ESCMID today.
In case of questions, please contact: observership@escmid.org

› Read more
 

Upcoming GARDP Webinar: Non-traditional antibacterial therapeutic options and challenges

Don’t miss the next GARDP Webinar taking place on Tuesday 4 February from 17:00-18:30 CET. This webinar will be on the topic of ‘Non-traditional antibacterial therapeutic options and challenges’, with speaker Ursula Theuretzbacher (CEFAIA, Austria) being joined by discussant Laura Piddock and chair Prabhavathi Fernandes (GARDP, Switzerland).

Visit the GARDP website to sign up for this, and to view previous webinars.

› Read more
 

CMI highlight: Global prevalence of latent toxoplasmosis in pregnant women: a systematic review and meta-analysis

Toxoplasmosis, caused by Toxoplasma gondii, an obligate intracellular protozoan parasite, is one of the most important infectious diseases during pregnancy. Congenital infection can result in abortion/stillbirth, hydrocephaly/microcephaly and ocular/neurological complications in childhood or early adulthood. Although most infections occur when women are infected during pregnancy, it can also occur via reactivation of a previously-acquired T. gondii infection, classified as latent. A. Rostami et al. designed a systematic review and meta-analysis to assess the worldwide prevalence of latent toxoplasmosis in pregnant women.

The results of this meta-analysis confirm that, worldwide, and during the time period of this study, approximately one third (33.6%) of pregnant women were seropositive for latent toxoplasmosis. The majority of studies analysed in this report were published after 2010, therefore, is representative of actual prevalence worldwide. The analysis showed variation by region, so a multi-national approach to examine these variations and their drivers is needed to inform action. The authors conclude that interventions to improve maternal health, through improved knowledge of potential risk factors, including nutritional sources and contact with cats, could help to reduce the risk of health problems arising from both primary and latent infections with T. gondii.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.